GIP has neuroprotective effects in Alzheimer and parkinsons disease models
The GLP-1 Big Pharma Journey The story of GLP-1 drugs spans decades and multiple pharmaceutical giants, including Eli Lilly and Novo Nordisk, which were involved from the early years
Normally, when your blood sugar begins to drop, your body can respond by making more blood sugar or burning up stored sugar
Daniela Hurtado Andrade, M.D., PhD, an endocrinologist at Mayo Clinic
Consider taking glutathione IV, while detoxing after drug or alcohol dependence or addiction as a highly efficient route of delivery
Research Background Preclinical studies have investigated Melanotan 2 as a non-selective agonist of the melanocortin receptors MC1R through MC5R